Diagnostic Imaging Agents Market Research Report Details: Emerging Economies Responsible To Drive Future Demand Across the World

The Diagnostic Imaging Agents Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

Get accurate market forecast and analysis on the Diagnostic Imaging Agents Market. Request a sample to stay abreast on the key trends impacting this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally.

Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents.

The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

Browse more detail information about diagnostic imaging agents market:

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

This release was published on openPR.